SAS Clinical Interview QUESTIONS and ANSWERS What is the therapeutic area you worked earlier? There are so many diff. therapeutic areas a pharmaceutical company can work…

1. Synergizing global best practices in the CRO industry 2. KREARA - India Market Access Services Patient Reported Outcome Research Post Marketing Surveillance Agile Software…

Slide 1Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia N Engl J Med. 2010 Mar 11;362(10):906-16. Paul W. Ladenson, M.D., Jens D. Kristensen,…

Slide 1Dr S B Squire, Reader in Clinical Tropical Medicine, LSTM, and Secretary of the TB & Poverty Subgroup The contribution of research to improving access to health…

Folie 1 Infusional 5-FU/FA plus Oxaliplatin (FUFOX) vs. Capecitabine plus Oxaliplatin (CAPOX) as first-line treatment for metastatic colorectal cancer: safety and efficacy…

1. HYPERHOMOCYSTEINEMIAAND ITS IMPLICATIONSIN ATHEROSCLEROSIS – THE INDIAN SCENARIOModerator – Dr. Manoj Mathur (MD)Presented By – Lakshya Kumar 2. What is homocysteine…

1. Category : Medical DevicesAll logos and Images mentioned on this slide belong to their respective owners.www.MarketResearchReports.com 2. Introduction to Report  Launch…

Slide 1Statistical Analysis Plan and Clinical Study Report Zibao Zhang ( 张子豹 ), PhD Associate Director, Biostatistics PPD China Presented at the 2nd Clinical Data Management…

Slide 1 Effect of Aliskiren on Postdischarge Outcomes Among Non-Diabetic Patients Hospitalized for Heart Failure: Insights from the ASTRONAUT Outcomes Trial Aldo P. Maggioni,…

Slide 1 Clinical Observation of Montelukast as a Partner Agent for Complementary Therapy Slide 2 Study Objectives To compare the clinical benefits of adding montelukast to…